Price Alert

Calliditas Therapeutics A... (CALT)

NASDAQ: CALT · Real-Time Price · USD

40.00

-0.04 (-0.10%)

At close: Sep 20, 2024, 10:00 PM

Calliditas Therapeutics AB (publ) Balance Sheet Statement

Financials in SEK. Fiscal year is January - December.

Fiscal Year	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	797.28M	810.32M	973.73M	786.88M	866.18M	1.01B	1.25B	736.16M	846.8M	825.41M	955.51M	1.16B	709.31M	867.35M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	27.21M	25.1M	24.2M	20.86M	16.62M	13.39M	11.21M	6.91M	5.81M	5.84M	3.92M	3.94M	3.94M	2.23M
Other Long-Term Assets	n/a	n/a	n/a	n/a	-1K	n/a	n/a	n/a	n/a	-2K	n/a	-1K	-1K	n/a
Receivables	222.59M	182.82M	188.19M	130.53M	146.37M	109.55M	80.99M	187.18M	52.87M	6.33M	n/a	n/a	27.28M	40.52M
Inventory	40.16M	29.3M	20.43M	16M	17.7M	12.16M	3.65M	582K	730K	1.13M	889K	n/a	-27.28M	-40.52M
Other Current Assets	n/a	76.46M	15.78M	102.59M	1K	84.39M	10.02M	2K	1K	50.64M	11.34M	36.87M	n/a	n/a
Total Current Assets	1.15B	1.1B	1.28B	1.04B	1.11B	1.22B	1.41B	973.1M	950.14M	896.48M	1.01B	1.26B	736.58M	907.87M
Property-Plant & Equipment	59.36M	65.39M	54.24M	55.51M	41.49M	42.56M	31.92M	35.86M	36.62M	37.51M	39.61M	21.28M	8.84M	5.88M
Goodwill & Intangibles	471.67M	472.07M	479.34M	476.51M	515.03M	485.09M	483.84M	487.35M	460.3M	400.95M	399.42M	484.69M	481.31M	470.24M
Total Long-Term Assets	592.74M	589.39M	625.4M	575.88M	595.56M	569.01M	540.77M	545.01M	508.15M	447.86M	447.14M	512.5M	494.97M	478.86M
Total Assets	1.75B	1.69B	1.9B	1.61B	1.71B	1.79B	1.95B	1.52B	1.46B	1.34B	1.46B	1.77B	1.23B	1.39B
Account Payables	151.01M	101.38M	100.56M	67.17M	72.04M	108M	160.4M	95.76M	81.67M	100.05M	67.97M	74.86M	59.26M	57.66M
Deferred Revenue	n/a	n/a	6.17M	n/a	n/a	n/a	-10.37M	n/a	n/a	n/a	3.39M	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	12.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	26.62M	33.38M	18.51M	25.93M	30.74M	202.08M	31.01M	14.8M	15.89M	14.1M	18.81M	10.64M	8.99M	6.71M
Total Current Liabilities	429.78M	408.17M	407.14M	344.71M	290.31M	310.08M	325.23M	220.12M	178.49M	167.07M	135.45M	140.07M	122.06M	117.21M
Long-Term Debt	982.49M	986.39M	939.51M	740.74M	759.05M	724M	713.03M	448.13M	437.39M	192.63M	189.16M	187.43M	3.48M	1.32M
Other Long-Term Liabilities	165.67M	77.74M	150.36M	82.45M	77.81M	108.61M	92.91M	70.39M	68.42M	65.52M	72.11M	14.44M	66.47M	63.98M
Total Long-Term Liabilities	1.21B	1.16B	1.16B	914.75M	914.47M	889.23M	861.48M	572.05M	558.71M	306.12M	316.18M	338.07M	138.79M	137.34M
Total Liabilities	1.64B	1.57B	1.57B	1.26B	1.2B	1.2B	1.19B	792.17M	737.2M	473.2M	451.63M	478.14M	260.85M	254.55M
Total Debt	1.01B	1.02B	979.13M	770.16M	779.56M	746.9M	728.82M	467.32M	458.03M	214.49M	213.22M	187.43M	3.48M	1.32M
Common Stock	2.4M	2.38M	2.38M	2.38M	2.38M	2.38M	2.38M	2.37M	2.36M	2.09M	2.09M	2.09M	2M	2M
Retained Earnings	n/a	n/a	-2.31B	n/a	n/a	n/a	-1.83B	-1.83B	-1.82B	-1.66B	-1.45B	-1.19B	-1.21B	-1.04B
Comprehensive Income	n/a	117.77M	-5.23M	350.05M	501.98M	587.02M	9.31M	0.00	n/a	-1K	-26.98M	n/a	n/a	-0.00
Shareholders Equity	106.79M	120.15M	334.81M	352.44M	504.37M	589.4M	766.26M	725.94M	721.09M	871.14M	1.01B	1.26B	937.84M	1.1B
Total Investments	27.21M	25.1M	24.2M	20.86M	16.62M	13.39M	11.21M	6.91M	5.81M	5.84M	3.92M	3.94M	3.94M	2.23M